998 related articles for article (PubMed ID: 28297624)
1. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways.
Bullinger L; Döhner K; Döhner H
J Clin Oncol; 2017 Mar; 35(9):934-946. PubMed ID: 28297624
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukaemia genomics.
Medinger M; Passweg JR
Br J Haematol; 2017 Nov; 179(4):530-542. PubMed ID: 28653397
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
Orsmark-Pietras C; Landberg N; Lorenz F; Uggla B; Höglund M; Lehmann S; Derolf Å; Deneberg S; Antunovic P; Cammenga J; Möllgård L; Wennström L; Lilljebjörn H; Rissler M; Fioretos T; Lazarevic VL
Genes Chromosomes Cancer; 2021 Jun; 60(6):426-433. PubMed ID: 33433047
[TBL] [Abstract][Full Text] [Related]
4. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
[TBL] [Abstract][Full Text] [Related]
5. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations.
Devillier R; Gelsi-Boyer V; Brecqueville M; Carbuccia N; Murati A; Vey N; Birnbaum D; Mozziconacci MJ
Am J Hematol; 2012 Jul; 87(7):659-62. PubMed ID: 22535592
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of novel mutations in epigenetic modifiers in AML.
Abdel-Wahab O; Patel J; Levine RL
Hematol Oncol Clin North Am; 2011 Dec; 25(6):1119-33. PubMed ID: 22093580
[TBL] [Abstract][Full Text] [Related]
8. Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions.
DiNardo C; Lachowiez C
Curr Hematol Malig Rep; 2019 Oct; 14(5):386-394. PubMed ID: 31350639
[TBL] [Abstract][Full Text] [Related]
9. Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?
Madanat YF; Kalaycio ME; Nazha A
Acta Med Acad; 2019 Apr; 48(1):35-44. PubMed ID: 31264431
[TBL] [Abstract][Full Text] [Related]
10. Subtype-specific patterns of molecular mutations in acute myeloid leukemia.
Rose D; Haferlach T; Schnittger S; Perglerová K; Kern W; Haferlach C
Leukemia; 2017 Jan; 31(1):11-17. PubMed ID: 27285584
[TBL] [Abstract][Full Text] [Related]
11. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: the value of next-generation sequencing for genomic classification.
de Noronha TR; Mitne-Neto M; Chauffaille ML
J Investig Med; 2017 Dec; 65(8):1155-1158. PubMed ID: 28923882
[TBL] [Abstract][Full Text] [Related]
12. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
Yang F; Anekpuritanang T; Press RD
Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
[TBL] [Abstract][Full Text] [Related]
13. Real-world genomic profiling of acute myeloid leukemia and the impact of European LeukemiaNet risk stratification 2022 update.
da Rosa SEA; de Lima LB; Silveira CN; Cortes LGF; de Oliveira Filho JB; de Souza Reis R; Cervato MC; Rodrigues PHS; de Oliveira Pelegrino K; Petroni RC; da Silva Araujo E; Campregher PV
Clin Transl Oncol; 2023 Dec; 25(12):3431-3436. PubMed ID: 37165281
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutations precede acute myeloid leukemia years before diagnosis.
Desai P; Mencia-Trinchant N; Savenkov O; Simon MS; Cheang G; Lee S; Samuel M; Ritchie EK; Guzman ML; Ballman KV; Roboz GJ; Hassane DC
Nat Med; 2018 Jul; 24(7):1015-1023. PubMed ID: 29988143
[TBL] [Abstract][Full Text] [Related]
15. [AML in Adults - An Update on Diagnosis, Risk Classification and Therapy].
Spiekermann K; Shen AS
Dtsch Med Wochenschr; 2018 Sep; 143(18):1297-1303. PubMed ID: 30199909
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways.
Magotra M; Sakhdari A; Lee PJ; Tomaszewicz K; Dresser K; Hutchinson LM; Woda BA; Chen BJ
Histopathology; 2016 Dec; 69(6):1055-1065. PubMed ID: 27458708
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related acute myeloid leukemia developing 14 years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin.
Martín I; Navarro B; Villamón E; Solano C; Serrano A; Calabuig M; Amat P; Domingo F; Abellán R; García F; Olivares MD; Chaves FJ; Tormo M; Hernández-Boluda JC
Exp Mol Pathol; 2018 Aug; 105(1):139-143. PubMed ID: 30017658
[TBL] [Abstract][Full Text] [Related]
18. Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutations.
Shin SY; Lee ST; Kim HJ; Cho EH; Kim JW; Park S; Jung CW; Kim SH
Oncotarget; 2016 Aug; 7(34):54825-54837. PubMed ID: 27359055
[TBL] [Abstract][Full Text] [Related]
19. The evolving molecular genetic landscape in acute myeloid leukaemia.
Sanders MA; Valk PJ
Curr Opin Hematol; 2013 Mar; 20(2):79-85. PubMed ID: 23380602
[TBL] [Abstract][Full Text] [Related]
20. Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.
Wang BH; Li YH; Yu L
Chin Med J (Engl); 2015 Sep; 128(17):2395-403. PubMed ID: 26315090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]